Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DH.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XGNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.27NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.6.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.11.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.129 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.2.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.8.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.1.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.34NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.15.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.9.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FA.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
ER.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.1.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CQ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BL.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.59NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BR.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.5.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBDNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EB.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CN.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BG.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.1.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.576NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.325NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used